PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Standardized aqueous root extract showed a dose-dependent reduction in serum creatinine, β2-microglobulin, and blood urea nitrogen, and attenuated renal parenchymal injury in Wistar rats [PMID:34396545]
Preclinical studies have demonstrated efficacy in mitigating inflammation, alleviating pain, combating microbial infections, and exhibiting anticancer and antidiabetic effects [PMID:41008619]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34215988 (2021) — Chrysopogon zizanioides-a review on its pharmacognosy, chemical composition and pharmacological activities. · Environmental science and pollution research international
- 2.PMID: 19810597 (2009) — Vetiver grass, Vetiveria zizanioides: a choice plant for phytoremediation of heavy metals and organic wastes. · International journal of phytoremediation
- 3.PMID: 26588814 (2016) — Adaptation and detoxification mechanisms of Vetiver grass (Chrysopogon zizanioides) growing on gold mine tailings. · International journal of phytoremediation
- 4.PMID: 41008619 (2025) — Pharmacological and Therapeutic Potential of Chrysopogon zizanioides (Vetiver): A Comprehensive Review of Its Medicinal Applications and Future Prospects. · Biomolecules
- 5.PMID: 33534103